609-full
TomBerdine
Sex: M
Data Quality: 2 stars
Parkinson's: 13 yrs
Hoehn-Yahr 3 Type: Parkinson's disease Off
Mouth/throat: moderate
Arms: moderate
Chest: mild
Legs: mild
TomBerdine
Male, 46 years
Albuquerque, NM
Primary Condition
Parkinson's and 1 more ▼
Type
Parkinson's disease
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

TomBerdine's Stalevo is for:

  • Other
  • Parkinson's

TomBerdine has not reported any side effects for Stalevo.

TomBerdine's Stalevo History (Stopped)
Stalevo (carbidopa-entacapone-levodopa)
6 mg Daily Sep 22, 2006 - Feb 01, 2008
250 mg Daily Feb 01, 2008 - May 20, 2009
Stopped Other May 20, 2009
Evaluations
Date Dosage Other Perceived effectiveness Parkinson's Disease Perceived effectiveness Side Effects Adherence Burden
Aug 20, 2008 250 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone UsuallyUsuallyUsuallyUsually Not at allNot at allNot at allNot at all
Date
Aug 20, 2008
Advice & Tips
Longer lasting then the PARCOPA but much slower to take effect. About 45minutres to an hour. But last up to 3hours where the PARCOPA lasts only an hour or a little more.
Cost
< $25 monthly

About Stalevo (Prescription Drug)

Stalevo is a brand name for a combination of the drugs levodopa, carbidopa, and entacapone. Levodopa is the precursor to dopamine, carbidopa slows the breakdown of levodopa, while entacapone improves the efficacy of levodopa.

Learn more about Stalevo in our Stalevo Community Report.

Back to TomBerdine's Profile